Rıza Serttaş

9PUBLICATIONS
12CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Molecular targetsPredictive and prognostic markersEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
Serum GPVI for Diagnostic Assessment and Short-Term Risk Stratification in Patients with Suspected Transient Ischemic Attack: A Prospective Observational Cohort Study.

|Apr 09, 2026
Targeted elimination of CD44+ prostate cancer stem cells using hyaluronic acid-coated selenium nanoparticles co-loaded with apigenin.

Sinan Vicil, Riza Serttas, Suat Erdogan

|Sep 24, 2025
Esculetin inhibits TGF-β2-induced proliferation and epithelial-mesenchymal transition of retinal pigment epithelial cells.

Abdulkadir Can Çınar, Ayça Küpeli Çınar, Riza Serttas

|Nov 29, 2024
As shown hesperidin suppresses TGF-β2-induced proliferation and epithelial-mesenchymal transition of retinal pigment epithelial cells.

Ayça Küpeli Çınar, Riza Serttas, Abdulkadir Can Çınar

|Mar 14, 2024
Multifaceted impact of adipose conditioned media: Obesity-driven promotion of prostate cancer and cancer stem cell dynamics.

Suat Erdogan, Riza Serttas, Ilker Dibirdik

|Aug 11, 2023
Inhibition of Ribonucleotide Reductase Induces Endoplasmic Reticulum Stress and Apoptosis, Leading to the Death of Docetaxel-resistant Prostate Cancer Cells.

Riza Serttas, Suat Erdogan

Pageof 2

Frequent Collaborators

8 joint publications

Suat Erdogan

3 joint publications

Ayça Küpeli Çınar

2 joint publications

Kader Turkekul

2 joint publications

Ilker Dibirdik